Peptide
BPC-157
BPC-157 is a synthetic peptide of 15 amino acids, based on a fragment of a protein in gastric juice.
Also listed as PL 14736, PL-10, Bepecin
Does US compounding access mean FDA approval?
No. As checked on October 29, 2026, a US Department of Health and Human Services (HHS) policy describes conditional enforcement discretion for specified BPC-157 acetate preparations made for individual patients while rulemaking continues. That means a limited enforcement approach, not approval. The document explicitly states that compounded drugs have not undergone FDA review for safety, effectiveness or quality. 1
Sources
- HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances US Department of Health and Human Services, 2026